DoctorsProofNPPES directory · verify at state boards

Pulmonary Disease in Spartanburg, SC

10 verified pulmonary disease doctors in Spartanburg.

Pulmonologists diagnose and treat diseases of the lungs and respiratory system, such as asthma, COPD, and sleep apnea.

NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.

Verify a license at the South Carolina Board of Medical Examiners

Dr. Christopher Powers, MD

Pulmonary Disease

20 yrs NPPES
NPI 1285605295
101 E WOOD ST, Spartanburg, SC 29303(864) 560-6012
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Wilson Smith, MD

Pulmonary Disease

20 yrs NPPES
NPI 1982675625
2030 N CHURCH PLACE, Spartanburg, SC 29303(864) 582-6858
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $2,749 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$2,749

Total received

120

Transactions

22

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$599.13
Actelion Pharmaceuticals US, Inc.$325.68
GlaxoSmithKline, LLC.$269.67
Boehringer Ingelheim Pharmaceuticals, Inc.$268.67
Gilead Sciences, Inc.$239.08
Grifols USA, LLC$196.75

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 88th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Wilson Smith do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Charles Fogarty, MD

Pulmonary Disease

20 yrs NPPES
NPI 1316919194
2030 N CHURCH PLACE, Spartanburg, SC 29303(864) 558-2685
NPPES public registry
CMS Open Payments· $3,593,232 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$3,593,232

Total received

2,752

Transactions

20

Paying companies

Top paying companies

ModernaTX, Inc.$1,569,324
AstraZeneca Pharmaceuticals LP$1,178,682
Novavax Inc$155,418
Janssen Research & Development, LLC$127,462
Janssen Pharmaceuticals, Inc$121,430
GlaxoSmithKline, LLC.$111,712

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 100% of that group — among the highest recipients.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Charles Fogarty do not imply any wrongdoing. Many are meals, education, or research support.

Dr. John Clark, MD

Pulmonary Disease

20 yrs NPPES
NPI 1194798595
2030 NORTH CHURCH PLACE, Spartanburg, SC 29303(864) 582-6858
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $2,772 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$2,772

Total received

120

Transactions

21

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$778.71
GlaxoSmithKline, LLC.$312.70
Actelion Pharmaceuticals US, Inc.$240.99
Boehringer Ingelheim Pharmaceuticals, Inc.$221.87
Regeneron Healthcare Solutions, Inc.$202.21
Gilead Sciences, Inc.$162.26

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 88th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to John Clark do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Rico V Mendoza, MD

Pulmonary Disease

20 yrs NPPES
NPI 1861466021
2030 N CHURCH PLACE, Spartanburg, SC 29303(864) 582-6858
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,969 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,969

Total received

54

Transactions

16

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$774.25
GlaxoSmithKline, LLC.$374.71
Gilead Sciences, Inc.$162.13
Electromed, Inc.$128.09
Jazz Pharmaceuticals Inc.$113.11
Mylan Specialty L.P.$85.34

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 86th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Rico V Mendoza do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Joseph Boscia, MD

Pulmonary Disease

20 yrs NPPES
NPI 1669437257
151 HAROLD FLEMING COURT, Spartanburg, SC 29303(864) 573-6320
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $717,502 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$717,502

Total received

308

Transactions

34

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$174,953
AstraZeneca Pharmaceuticals LP$114,761
Pfizer Inc.$91,689
Abbott Laboratories$86,200
Mylan Specialty L.P.$76,466
Amphastar Pharmaceuticals, Inc.$66,022

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 100% of that group — among the highest recipients.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Joseph Boscia do not imply any wrongdoing. Many are meals, education, or research support.

Dr. David Erb, MD

Pulmonary Disease

20 yrs NPPES
NPI 1952366478
151 HAROLD FLEMING COURT, Spartanburg, SC 29303(864) 573-6320
NPPES public registry
CMS Open Payments· $1,687,852 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,687,852

Total received

1,630

Transactions

26

Paying companies

Top paying companies

ModernaTX, Inc.$903,452
AstraZeneca Pharmaceuticals LP$247,598
Seqirus USA Inc$145,572
Janssen Pharmaceuticals, Inc$77,270
Novavax Inc$62,664
Genentech, Inc.$61,650

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 100% of that group — among the highest recipients.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to David Erb do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Farhan Siddiqui, MD

Pulmonary Disease

19 yrs NPPES
NPI 1447461579
151 HAROLD FLEMING CT, Spartanburg, SC 29303(864) 573-6320
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,693,971 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,693,971

Total received

1,181

Transactions

39

Paying companies

Top paying companies

ModernaTX, Inc.$903,667
Pfizer Inc.$347,213
Seqirus USA Inc$189,086
Eli Lilly and Company$135,715
Amphastar Pharmaceuticals, Inc.$55,269
Chiesi USA, Inc.$26,180

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 100% of that group — among the highest recipients.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Farhan Siddiqui do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Sau Yin Wan, MD

Pulmonary Disease

18 yrs NPPES
NPI 1831350271
151 HAROLD FLEMING COURT, Spartanburg, SC 29303(864) 573-6320
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $40.18 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$40.18

Total received

2

Transactions

2

Paying companies

Top paying companies

AbbVie Inc.$23.82
Inari Medical, Inc.$16.36

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 53th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Sau Yin Wan do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Supinder Channa, MD

Pulmonary Disease

10 yrs NPPES
NPI 1427509611
151 HAROLD FLEMING CT, Spartanburg, SC 29303(864) 573-6320
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,954 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,954

Total received

108

Transactions

23

Paying companies

Top paying companies

Boehringer Ingelheim Pharmaceuticals, Inc.$329.15
GlaxoSmithKline, LLC.$278.81
AstraZeneca Pharmaceuticals LP$235.57
Electromed, Inc.$222.64
Regeneron Healthcare Solutions, Inc.$148.16
Grifols USA, LLC$103.26

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 86th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Supinder Channa do not imply any wrongdoing. Many are meals, education, or research support.

Pulmonary Disease in Spartanburg, SC — Verified | DoctorsProof | DoctorsProof